bpc 157 and dap BPC-157 FDA Approval Status: Is It Approved for Human Use? BPC-157: Experimental Peptide Creates Risk

It requires that all components necessary for the manufacture of a finished drug product - active ingredients, excipients, containers and closure systems - must be tested to the defined specifications after receipt of the goods and before release for further processing

Body Protection Compound 157 is a synthetic 15-amino-acid peptide derived from a cytoprotective fragment of human gastric juice protein

These are the same kinds of reactions seen across topical actives generally and are not specific to AHK-Cu they reflect applying a concentrated preparation to skin rather than anything unique to the peptide

Karol, A